EqualOcean has learned that on May 14th, Nthopoic (中景纬视) , committed to opening a new era of human vision science with cutting-edge technology, successfully completed a pre-A round financing of tens of millions of yuan recently after obtaining angel investment in 2023.
This round of financing was led by ReinFore Capital(瑞华资本), with follow-up investments from TigerYeah Investment(泰煜投资) and Borchid Capital(蜂巧资本). G&G Capital(歌路资本) has served as the exclusive financial advisor for a long time. This round of financing will help Nthopoic continue to advance clinical research, market promotion, brand building, and new technology research and development, develop more innovative eye health products, effectively address unmet clinical needs and pain points, and lead a new trend in eye health consumption.
Established in February 2022, Nthopoic is dedicated to the independent research and development of innovative technologies in the field of ophthalmic vision. It has globally leading eye health technology and collaborates with core research teams from world-renowned vision research centers. It is committed to providing professional, convenient, efficient, and medical eye health products to global users, and is an innovative technology company integrating research and development, production, and marketing.
The core mechanism of existing myopia control products is to stimulate the peripheral area of the retina with static optical signals through refractive means ("peripheral defocus"). However, constant optical signal queues easily induce neural adaptation of the optic nerve, leading to the saturation of myopia control effects over time . Based on the original theory of spatiotemporal optical phase technology, Nthopoic has launched the unique innovative product category - STOP KIT™ dynamic spatiotemporal optical film, effectively solving the problem of static defocus saturation.
STOP KIT™ - dynamic spatiotemporal optical film is the first innovative product of Nthopoic. The company has successfully developed composite new materials, combined with patented microstructure design and optical engraving technology, and first realized its medical clinical application, providing a long-lasting complete solution for myopia control in adolescents. STOP KIT™ provides comfortable visual quality and, relying on lithography technology, forms irregular droplet-shaped microstructures with dynamic refractive power on the material surface, thereby introducing optical indices of time, space, and phase, and having a complex surface, asymmetrical direction optical design. The product material can be widely used on the front surface of optical lenses, retaining the original refractive effect of the optical lens and producing dynamic optical signals stimulating the retina in all directions, thus achieving lasting myopia control effects. In addition, STOP KIT™ performs well in patient compliance, visual quality, and ease of use, bringing a comprehensive new experience to myopia control patients.
EqualOcean understands that myopia has become a highly prevalent disease globally. According to statistics from international authoritative institutions, it is estimated that by 2050, the global number of myopia patients will reach 5 billion. According to statistics from the National Bureau of Statistics of China, as of the end of 2023, the scale of the national myopia prevention and control industry reached CNY 21 billion, an increase of over 50% compared to 2019. China's youth myopia rate has been ranked first in the world for many years. With the high attention paid by the country to the prevention and control of youth myopia, the sustained consumption of myopia prevention and control has formed a long-term growth trend, which will inevitably grow into a trillion-level track.
In just two years, Nthopoic has pushed its globally unique STOP KIT™ dynamic spatiotemporal optical film into the commercialization stage, fully demonstrating the excellent technology transformation, commercialization capabilities, and pragmatic business philosophy of the founding team. In addition to the STOP KIT™ dynamic spatiotemporal optical film products, the company has also laid out wearable devices for dry eye, digital eye vision peripherals, presbyopia correction, and other products. The leading scientific team has mastered the most cutting-edge research and development in vision science, and has successfully developed several heavyweight vision products and achieved commercialization. Based on this, in the future, Nthopoic will continue to develop the world's most cutting-edge technology and products in the field of eye health consumer medical care to meet the eye health needs of users of all ages in their daily lives.